Healio

Long-term P2Y12 inhibitor monotherapy after PCI reduces bleeding at 3 years vs. DAPT

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Long-term P2Y12 inhibition after PCI reduced bleeding at ...
Medscape

PANTHER: Should Clopidogrel Become the 'New Aspirin' in CAD?

A P2Y12 inhibitor, such as clopidogrel or ticagrelor, might be a better choice than aspirin for antiplatelet monotherapy in patients with coronary artery disease, results of a new meta-analysis ...
TCTMD

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

BARCELONA, Spain—(UPDATED) Aspirin has long been the antiplatelet of choice for long-term secondary prevention in patients with coronary disease, but a meta-analysis of several trials suggests P2Y12 ...
TCTMD

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

For long-term secondary prevention of MI, the use of P2Y12 monotherapy has a borderline advantage over aspirin alone and does not affect bleeding, according to a meta-analysis of nine randomized ...
Healio

A look at the interaction between opioids and oral P2Y12 inhibitors

A recently recognized drug-drug interaction between opioids and P2Y12 inhibitors may have clinical implications for patients with ACS. Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is ...